• Donald Melson has been named vice president, corporate controller of Analogic (Peabody, Massachusetts). Melson most recently served as vice president and corporate controller of Millipore. Melson succeeds Michael Siraco, who had served as Analogic's vice president, corporate controller since 1982. Siraco will continue to serve as vice president, finance. Analogic is a manufacturer of advanced health and security systems and subsystems sold primarily to OEMs.

• Mansoor Mohammed, PhD, has joined CombiMatrix Molecular Diagnostics (Mukilteo, Washington) as chief scientific officer. Mohammed has been at the forefront of research and development in the fields of comparative genomic hybridization and microarray technologies for his entire professional career. Between 2001 and 2003 he produced the first commercially viable whole genome Bacterial Artificial Chromosome array and co-authored one of its seminal clinical applications. Mohammed later directed the advanced technologies and genomics program at Quest Diagnostics. CombiMatrix, a unit of Acacia Research, is developing a platform technology to rapidly produce customizable arrays.

• Health Care REIT (Toledo, Ohio), a real estate investment trust that invests in healthcare and senior housing properties, reported several management promotions and appointments. Scott Estes has been promoted to senior vice president and CFO from vice president of finance. Raymond Braun, who has served as president and CFO since May 2002, will continue to serve as president of the company. In addition, Charles Herman Jr. has been promoted to executive vice president and chief investment officer from vice president and chief investment officer; Jeffrey Miller to executive vice president and general counsel from vice president and general counsel; Erin Ibele to senior vice president, administration and corporate secretary from vice president, administration and corporate secretary; and Michael Crabtree to vice president and treasurer from treasurer. Jay Morgan has been appointed to the newly created position of vice president, acute care investments, and Joseph Weisenburger to the newly created position of vice president, senior housing. Morgan was most recently a vice president in the real estate investment banking group at Lehman Brothers. Weisenburger has been with the company since 1998, most recently serving as an investment officer.

• Rob Bancroft has been appointed senior vice president, sales and marketing for Healthpoint's Tissue Management Division (Fort Worth, Texas). Bancroft was most recently vice president of marketing, tissue management, a position he has held since joining Healthpoint in 2004. Healthpoint is a DFB Pharmaceuticals affiliate company. Its Tissue Management business includes marketing prescription drugs and prescription technologies and devices for skin and soft tissue, including the treatment of acute and chronic tissue compromises and full and partial thickness wounds, and for the management of intact skin.

• Phil Mazzuca will join MedCath (Charlotte, North Carolina) March 27 as chief operating officer. Most recently, Mazzuca led the Florida and Texas division of IASIS Healthcare. Before that, Mazzuca was CEO of Town & Country Hospital, an IASIS facility. MedCath develops, owns and operates hospitals in partnership with physicians. While each of its hospitals is licensed as a general acute care hospital, MedCath focuses on cardiovascular care.

No Comments